JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184990

Anti-APOBEC3B antibody [EPR18138]

5

(3 Reviews)

|

(17 Publications)

Rabbit Recombinant Monoclonal APOBEC3B antibody. Suitable for WB and reacts with Transfected cell lysate - Human, Human samples. Cited in 17 publications.

View Alternative Names

DNA dC->dU-editing enzyme APOBEC-3B, A3B, Phorbolin-1-related protein, Phorbolin-2/3, APOBEC3B

5 Images
Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
  • WB

Lab

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)

Negative sample : SK-BR-3 (PMID : 27634334).

Merged signal (red and green).
Green - ab184990 observed at 38 kDa.
Red - loading control, ab8245 observed at 36 kDa.

ab184990 Anti-APOBEC3B antibody [EPR18138] was shown to specifically react with APOBEC3B in wild-type HeLa cells. Loss of signal was observed when APOBEC3B CRISPR-Edited HeLa cell line was used. Wild-type and APOBEC3B CRISPR-Edited HeLa samples were subjected to SDS-PAGE.

ab184990 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively.

Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

APOBEC3B CRISPR-Edited HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 3:

A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

SK-BR-3 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Lanes 1 - 4:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution

Observed band size: 38 kDa

false

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
  • WB

Lab

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)

Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM /TBST We are unsure of the identity of the 55kda band.

All lanes:

Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/500 dilution

All lanes:

A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 46 kDa

Observed band size: 38 kDa

false

Exposure time: 180s

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
  • WB

Collaborator

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)

Blocking buffer : 5% NFDM/TBST.

Dilution buffer : 1% NFDM/TBST.

Exposure time : Panel A : 20 s; Panel B : 1 min.

Figure provided by Dr. Jenni Nikkila. Gene Function Lab at The Institute of Cancer Research, London. HEK293-APOBEC3B(+GFP) tetracycline-inducible cell line provide by Dr Reuben Harris, University of Minnesota, Minneapolis - cited in Akre, M.K, G.J. Starrett, J.S. Quist, N.A. Temiz, M.A. Carpenter, A.N.J. Tutt, A. Grigoriadis & R.S. Harris (2016) Mutation processes in 293-based clones overexpressing the DNA cytosine deaminase APOBEC3B. PLoS One11(5) : e0155391. doi : 10.1371/journal.pone.0155391.

The 35 kDa band represents a known splice variant of APOBEC3B.

All lanes:

Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/10000 dilution

Lane 1:

HepaRG-APOBEC3B tetracycline-inducible cell line (+/-) at 20 µg

Lane 2:

HCC1143 cell line infected with control (+) and APOBEC3B lentivirus (-) at 20 µg

Lane 3:

HEK293-APOBEC3B(+GFP) tetracycline-inducible cell line (+/-) at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (H+L) conjugated to HRP at 1/10000 dilution

Predicted band size: 46 kDa

Observed band size: 35 kDa,70 kDa

false

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
  • WB

Lab

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)

Exposure time : Lane 1-3 : 20 seconds; Lane 4-5 : 180 seconds

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.

ab184990 only detects very weak signal in HepG2 and HeLa cell lines.

All lanes:

Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution

Lane 1:

A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 2 and 4:

HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 3 and 5:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 38 kDa

false

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)
  • WB

Supplier Data

Western blot - Anti-APOBEC3B antibody [EPR18138] (AB184990)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-APOBEC3B antibody [EPR18138] (ab184990) at 1/1000 dilution

Lane 1:

Human APOBEC3B fragment recombinant protein at 0.01 µg

Lane 2:

Human APOBEC3G fragment recombinant protein at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution

Predicted band size: 46 kDa

Observed band size: 46 kDa

false

  • Carrier free

    Anti-APOBEC3B antibody [EPR18138] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18138

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

An additional band is detected in Western Blot by ab184990 at 50/55kD in most samples. We do not know the identity of this band.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/10000", "WB-species-notes": "<p></p>" }, "Transfected cell lysate - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

APOBEC3B also known as Apolipoprotein B mRNA editing enzyme catalytic subunit 3B is a protein that plays a role in DNA cytosine deamination. It selectively deaminates cytosine bases in DNA to uracil resulting in mutations. The protein has a molecular mass of approximately 46 kDa. APOBEC3B expression occurs primarily in the liver and testes but it can also be detected in other tissues.
Biological function summary

APOBEC3B functions as part of the innate immune defense by restricting viral replication through inducing hypermutation in viral genomes. It does not form a stable complex but can act in conjunction with other APOBEC3 family members. APOBEC3B activity is critical in the context of host-virus interactions especially in the defense against retroviruses and other viruses.

Pathways

Scientists classify APOBEC3B within the viral restriction and DNA damage response pathways. In these pathways the protein works alongside other DNA repair proteins such as AID (Activation-Induced cytidine Deaminase). APOBEC3B participates in editing events that provide insights into virus-host co-evolution and resilience against viral infections.

Researchers have linked APOBEC3B to cancer development due to its ability to induce genetic mutations. Its mutagenic activity connects it with a variety of cancers including breast cancer and head and neck cancer. Through these diseases the protein shows functional connections to other DNA mutators and repair proteins that it affects or interacts with during tumorigenesis.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity against simian immunodeficiency virus (SIV), hepatitis B virus (HBV) and human T-cell leukemia virus type 1 (HTLV-1) and may inhibit the mobility of LTR and non-LTR retrotransposons.
See full target information APOBEC3B

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Heliyon 10:e32139 PubMed38868014

2024

APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaying Shen,Xinxin Xu,Junyan Fan,Hongsen Chen,Yue Zhao,Weijin Huang,Wenbin Liu,Zihan Zhang,Qianqian Cui,Qianqian Li,Zheyun Niu,Dongming Jiang,Guangwen Cao

Cell death & disease 14:348 PubMed37270643

2023

APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Chunyan Zong,Zhe Zhang,Li Gao,Jie He,Yiran Wang,Qian Li,Xiaoting Liu,Jie Yang,Di Chen,Rui Huang,Guopei Zheng,Xiaoliang Jin,Wu Wei,Renbing Jia,Jianfeng Shen

Journal of cancer research and clinical oncology 149:4639-4651 PubMed36175801

2022

Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.

Applications

Unspecified application

Species

Unspecified reactive species

Shanshan Shi,Tong Wu,Zechen Ma,Xiudi Zhang,Ke Xu,Qi Tian,Liming Gao,Xiaobo Yin,Shufeng Xu,Shengbo Yang

Nature 607:799-807 PubMed35859169

2022

Mechanisms of APOBEC3 mutagenesis in human cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Mia Petljak,Alexandra Dananberg,Kevan Chu,Erik N Bergstrom,Josefine Striepen,Patrick von Morgen,Yanyang Chen,Hina Shah,Julian E Sale,Ludmil B Alexandrov,Michael R Stratton,John Maciejowski

Frontiers in oncology 11:658139 PubMed34660257

2021

CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zuowei Shi,Kaifu Wang,Yufei Xing,Xuefeng Yang

Journal of virology 95:e0117021 PubMed34523960

2021

APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.

Applications

Unspecified application

Species

Unspecified reactive species

Susana Bandarra,Eri Miyagi,Ana Clara Ribeiro,João Gonçalves,Klaus Strebel,Isabel Barahona

Nucleic acids research 49:7492-7506 PubMed34197599

2021

Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.

Applications

Unspecified application

Species

Unspecified reactive species

Samuel B Bader,Tiffany S Ma,Charlotte J Simpson,Jiachen Liang,Sakura Eri B Maezono,Monica M Olcina,Francesca M Buffa,Ester M Hammond

Nature genetics 52:884-890 PubMed32719516

2020

APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis.

Applications

Unspecified application

Species

Unspecified reactive species

John Maciejowski,Aikaterini Chatzipli,Alexandra Dananberg,Kevan Chu,Eleonore Toufektchan,Leszek J Klimczak,Dmitry A Gordenin,Peter J Campbell,Titia de Lange

Nature communications 11:2971 PubMed32532990

2020

Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.

Applications

Unspecified application

Species

Unspecified reactive species

Pégah Jalili,Danae Bowen,Adam Langenbucher,Shinho Park,Kevin Aguirre,Ryan B Corcoran,Angela G Fleischman,Michael S Lawrence,Lee Zou,Rémi Buisson

NAR cancer 2:zcaa005 PubMed34316685

2020

deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kiminori Kurashima,Hideto Kashiwagi,Iwao Shimomura,Ayako Suzuki,Fumitaka Takeshita,Marianne Mazevet,Masahiko Harata,Takayuki Yamashita,Yusuke Yamamoto,Takashi Kohno,Bunsyo Shiotani
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com